<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JRS</journal-id>
<journal-id journal-id-type="hwp">spjrs</journal-id>
<journal-id journal-id-type="nlm-ta">Royal Society of Medicine</journal-id>
<journal-title>Journal of the Royal Society of Medicine</journal-title>
<issn pub-type="ppub">0141-0768</issn>
<issn pub-type="epub">1758-1095</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0141076813498233</article-id>
<article-id pub-id-type="publisher-id">10.1177_0141076813498233</article-id>
<article-categories>
    <subj-group subj-group-type="heading">
<subject>Letters</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>No clear boundary between placebo and effective treatment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Hubbeling</surname><given-names>Dieneke</given-names></name>
<xref ref-type="corresp" rid="corresp1-0141076813498233"/>
</contrib>
</contrib-group>
<aff id="aff1-0141076813498233">South West London and St. George's Mental Health Trust, London, SW17 7DJ, UK</aff>
<author-notes>
<corresp id="corresp1-0141076813498233">Email: <email>d.hubbeling@btinternet.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2013</year>
</pub-date>
<volume>106</volume>
<issue>8</issue>
<fpage seq="b">303</fpage>
<lpage>304</lpage>
<permissions>
<copyright-statement>© The Royal Society of Medicine</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="society">The Royal Society of Medicine</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>In a recent editorial, Justman<sup><xref ref-type="bibr" rid="bibr1-0141076813498233">1</xref></sup> discussed the use of placebos in clinical practice. Of all the GPs who used pure placebos, fewer than one in ten reported that they explained to the patient that they were prescribing a placebo, according to a study by Howick <italic>et al</italic>.<sup><xref ref-type="bibr" rid="bibr2-0141076813498233">2</xref></sup> According to the same study GPs also disapproved of deception. Justman<sup><xref ref-type="bibr" rid="bibr1-0141076813498233">1</xref></sup> suggested that GPs might well be inconsistent by disapproving of deception and not telling patients that they are prescribed a placebo.</p>
<p>Howick <italic>et al</italic>.<sup><xref ref-type="bibr" rid="bibr2-0141076813498233">2</xref></sup> made a difference between pure placebos (such as sugar-coated pills) and impure placebos (such as peppermint pills). However, there is no sharp dividing line between pure placebo, impure placebo and active treatment. The word ‘placebo response’ is a misnomer, because a therapeutic response to an effective treatment can consist of a placebo component.<sup><xref ref-type="bibr" rid="bibr3-0141076813498233">3</xref></sup> Research into depression suggests that patients sometimes respond to pure placebos and this correlates with changes in brain physiology.<sup><xref ref-type="bibr" rid="bibr4-0141076813498233">4</xref></sup> One can wonder whether one of the examples of impure placebos from Howick’s study,<sup><xref ref-type="bibr" rid="bibr2-0141076813498233">2</xref></sup> peppermint pills, really has no genuine therapeutic effects for pharyngitis, although it is probably the sucking on the pills and not the peppermint. Because there is no sharp dividing line between placebo and active treatment, it is more useful to think about placebo as a form of treatment, which can be effective for some conditions such as depression and not for others such as cancer.</p>
<p>Practising doctors face a dilemma. They have to install hope, that the treatment will work and at the same time they have to give accurate information<sup><xref ref-type="bibr" rid="bibr5-0141076813498233">5</xref></sup> about advantages and disadvantages of the proposed treatment. Mentioning the word placebo can be counterproductive, and it is not necessarily deception, if the word placebo is not used, given that even pure placebos can correlate with changes in the brain.</p>
</body>
<back>
<sec id="sec2-0141076813498233"><title>Competing interests</title>
<p>None declared</p></sec>
<ref-list><title>References</title>
<ref id="bibr1-0141076813498233"><label>1</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name><surname>Justman</surname><given-names>S</given-names></name></person-group><article-title>Placebos in the clinic</article-title><source>J R Soc Med</source><year>2013</year><volume>106</volume><fpage>208</fpage><lpage>9</lpage></nlm-citation></ref>
<ref id="bibr2-0141076813498233"><label>2</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name><surname>Howick</surname><given-names>J</given-names></name><name><surname>Bishop</surname><given-names>FL</given-names></name><name><surname>Heneghan</surname><given-names>C</given-names></name><etal/></person-group><article-title>Placebo use in the United Kingdom: results from a national survey of primary care practitioners</article-title><source>PloS One</source><year>2013</year><volume>8</volume><fpage>e58247</fpage></nlm-citation></ref>
<ref id="bibr3-0141076813498233"><label>3</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>FG</given-names></name><name><surname>Kaptchuk</surname><given-names>TJ</given-names></name></person-group><article-title>The power of context: reconceptualizing the placebo effect</article-title><source>J R Soc Med</source><year>2008</year><volume>101</volume><fpage>222</fpage><lpage>225</lpage></nlm-citation></ref>
<ref id="bibr4-0141076813498233"><label>4</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>IA</given-names></name><name><surname>Witte</surname><given-names>EA</given-names></name><name><surname>Morgan</surname><given-names>M</given-names></name><etal/></person-group><article-title>Changes in brain function of depressed subjects during treatment with placebo</article-title><source>Am J Psychiatr</source><year>2002</year><volume>159</volume><fpage>122</fpage><lpage>29</lpage></nlm-citation></ref>
<ref id="bibr5-0141076813498233"><label>5</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beste</surname><given-names>J</given-names></name></person-group><article-title>Instilling hope and respecting patient autonomy: reconciling apparently conflicting duties</article-title><source>Bioethics</source><year>2005</year><volume>19</volume><fpage>12</fpage><lpage>21</lpage></nlm-citation></ref></ref-list></back>
</article>